Ars Pharms Operation Drug Patent Portfolio
Ars Pharms Operation owns 1 orange book drug protected by 8 US patents Given below is the list of Ars Pharms Operation's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10682414 | Intranasal epinephrine formulations and methods for the treatment of disease | 06 Feb, 2039 | Active |
| US11191838 | Intranasal epinephrine formulations and methods for the treatment of disease | 06 Feb, 2039 | Active |
| US11717571 | Intranasal epinephrine formulations and methods for the treatment of disease | 06 Feb, 2039 | Active |
| US11744895 | Intranasal epinephrine formulations and methods for the treatment of disease | 06 Feb, 2039 | Active |
| US11918655 | Intranasal epinephrine formulations and methods for the treatment of disease | 06 Feb, 2039 | Active |
| US12324838 | Intranasal epinephrine formulations and methods for the treatment of disease | 06 Feb, 2039 | Active |
| US10576156 | Compositions for drug administration | 06 Feb, 2038 | Active |
| US11173209 | Compositions for drug administration | 06 Feb, 2038 | Active |
Ars Pharms Operation's Drug Patent Litigations
Ars Pharms Operation's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Aug 12, 2021, against patent number US10682414. The petitioner Amphastar Pharmaceuticals, Inc., challenged the validity of this patent, with Aegis Therapeutics, LLC et al. as the respondent. Click below to track the latest information on how companies are challenging Ars Pharms Operation's patents.
| Patent | Proceeding Filing Date | Status | Respondent | Petitioner |
|---|---|---|---|---|
 | ||||
| US10682414 | August, 2021 |
Final Written Decision
(09 Feb, 2023)
| Aegis Therapeutics, LLC et al. | Amphastar Pharmaceuticals, Inc. |
Ars Pharms Operation's Family Patents
Ars Pharms Operation Drug List
Given below is the complete list of Ars Pharms Operation's drugs and the patents protecting them.
1. Neffy
Neffy is protected by 8 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10682414 | Intranasal epinephrine formulations and methods for the treatment of disease |
06 Feb, 2039
(13 years from now)
| Active |
| US11191838 | Intranasal epinephrine formulations and methods for the treatment of disease |
06 Feb, 2039
(13 years from now)
| Active |
| US11717571 | Intranasal epinephrine formulations and methods for the treatment of disease |
06 Feb, 2039
(13 years from now)
| Active |
| US11744895 | Intranasal epinephrine formulations and methods for the treatment of disease |
06 Feb, 2039
(13 years from now)
| Active |
| US11918655 | Intranasal epinephrine formulations and methods for the treatment of disease |
06 Feb, 2039
(13 years from now)
| Active |
| US12324838 | Intranasal epinephrine formulations and methods for the treatment of disease |
06 Feb, 2039
(13 years from now)
| Active |
| US10576156 | Compositions for drug administration |
06 Feb, 2038
(12 years from now)
| Active |
| US11173209 | Compositions for drug administration |
06 Feb, 2038
(12 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Neffy's drug page